Medical Developments International Ltd Cash Flow Conversion Efficiency
Medical Developments International Ltd cash flow conversion efficiency. Based on the latest financial reports, Medical Developments International Ltd (MVP) has a cash flow conversion efficiency ratio of 0.013x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$709.00K ≈ $501.66K USD) by net assets (AU$55.10 Million ≈ $38.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Medical Developments International Ltd (2004–2025)
Cash flow conversion efficiency of Medical Developments International Ltd from 2004 to 2025. This chart illustrates how Medical Developments International Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Medical Developments International Ltd stock price today for real-time trading data and today's change.
Medical Developments International Ltd Cash Flow Conversion Ratio Explained
Medical Developments International Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Medical Developments International Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medical Developments International Ltd ranked by their cash flow conversion efficiency. Also see MVP stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Asset Vision Co Ltd
AU:ASV
|
0.082x |
|
Fold Holdings, Inc. Class A Common Stock
NASDAQ:FLD
|
-0.302x |
|
Ponni Sugars (Erode) Limited
NSE:PONNIERODE
|
0.037x |
|
BOS Better Online Solutions
NASDAQ:BOSC
|
0.176x |
|
Microlink Solutions Bhd
KLSE:0126
|
-0.327x |
|
ROCA INDUSTRY HOLDINGROCK1 S.A.
RO:ROC1
|
N/A |
|
KMH Hitech Co. Ltd
KQ:052900
|
-0.014x |
|
Malton Bhd
KLSE:6181
|
0.035x |
Annual Cash Flow Conversion Efficiency for Medical Developments International Ltd (2004–2025)
The table below shows the annual cash flow conversion efficiency of Medical Developments International Ltd from 2004 to 2025. Review free cash flow generation of Medical Developments International Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$55.10 Million ≈ $38.99 Million |
AU$-43.00K ≈ $-30.43K |
-0.001x | +99.67% |
| 2024-06-30 | AU$45.73 Million ≈ $32.36 Million |
AU$-10.78 Million ≈ $-7.63 Million |
-0.236x | -16.20% |
| 2023-06-30 | AU$81.31 Million ≈ $57.54 Million |
AU$-16.50 Million ≈ $-11.67 Million |
-0.203x | -8.40% |
| 2022-06-30 | AU$57.30 Million ≈ $40.54 Million |
AU$-10.72 Million ≈ $-7.59 Million |
-0.187x | -45.11% |
| 2021-06-30 | AU$68.30 Million ≈ $48.33 Million |
AU$-8.81 Million ≈ $-6.23 Million |
-0.129x | -3349.26% |
| 2020-06-30 | AU$43.34 Million ≈ $30.66 Million |
AU$172.00K ≈ $121.70K |
0.004x | -99.17% |
| 2019-06-30 | AU$44.59 Million ≈ $31.55 Million |
AU$21.27 Million ≈ $15.05 Million |
0.477x | +460.77% |
| 2018-06-30 | AU$21.04 Million ≈ $14.89 Million |
AU$1.79 Million ≈ $1.27 Million |
0.085x | -54.19% |
| 2017-06-30 | AU$21.60 Million ≈ $15.28 Million |
AU$4.01 Million ≈ $2.84 Million |
0.186x | -70.72% |
| 2016-06-30 | AU$19.02 Million ≈ $13.46 Million |
AU$12.07 Million ≈ $8.54 Million |
0.634x | +228.69% |
| 2015-06-30 | AU$17.41 Million ≈ $12.32 Million |
AU$3.36 Million ≈ $2.38 Million |
0.193x | +135.79% |
| 2014-06-30 | AU$15.82 Million ≈ $11.20 Million |
AU$1.29 Million ≈ $916.30K |
0.082x | +31.75% |
| 2013-06-30 | AU$15.73 Million ≈ $11.13 Million |
AU$977.00K ≈ $691.29K |
0.062x | -68.60% |
| 2012-06-30 | AU$16.17 Million ≈ $11.44 Million |
AU$3.20 Million ≈ $2.26 Million |
0.198x | -5.67% |
| 2011-06-30 | AU$14.46 Million ≈ $10.23 Million |
AU$3.03 Million ≈ $2.14 Million |
0.210x | +47.18% |
| 2010-06-30 | AU$12.71 Million ≈ $8.99 Million |
AU$1.81 Million ≈ $1.28 Million |
0.142x | +31.08% |
| 2009-06-30 | AU$11.81 Million ≈ $8.36 Million |
AU$1.28 Million ≈ $908.51K |
0.109x | +4.45% |
| 2008-06-30 | AU$11.80 Million ≈ $8.35 Million |
AU$1.23 Million ≈ $868.89K |
0.104x | -9.48% |
| 2007-06-30 | AU$11.02 Million ≈ $7.80 Million |
AU$1.27 Million ≈ $896.48K |
0.115x | -1.48% |
| 2006-06-30 | AU$9.87 Million ≈ $6.99 Million |
AU$1.15 Million ≈ $815.11K |
0.117x | +72.27% |
| 2005-06-30 | AU$8.40 Million ≈ $5.94 Million |
AU$569.00K ≈ $402.60K |
0.068x | +41.46% |
| 2004-06-30 | AU$8.37 Million ≈ $5.93 Million |
AU$401.00K ≈ $283.73K |
0.048x | -- |
About Medical Developments International Ltd
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analges… Read more